Original Research

Published on 09 Jul 2024

Developing an advanced diagnostic model for hepatocellular carcinoma through multi-omics integration leveraging diverse cell-death patterns

in Cancer Immunity and Immunotherapy

Chengbang Wang
Guanglin Yang
Guanzheng Feng
Chengen Deng
Qingyun Zhang
Shaohua Chen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1410603

498 views

Mini Review

Published on 09 Jul 2024

Tumor associated macrophages in breast cancer progression: implications and clinical relevance

in Cancer Immunity and Immunotherapy

Maria Stavrou
Anastasia Constantinidou

Frontiers in Immunology

doi 10.3389/fimmu.2024.1441820

167 views

Mini Review

Accepted on 08 Jul 2024

Targeting Mitochondrial Damage: Shining a New Light on Immunotherapy

in Cancer Immunity and Immunotherapy

Wenjuan Zeng
王梦慧
Yuxin Zhang
Taicheng Zhou
Zhen Zong

Frontiers in Immunology

doi 10.3389/fimmu.2024.1432633

Review

Accepted on 08 Jul 2024

Role of Tumor-Associated Macrophages in Hepatocellular Carcinoma: Impact, Mechanism and Therapy

in Cancer Immunity and Immunotherapy

Yinqi Zhang
Guoyong Han
Jian Gu
Zhiqiang Chen
Jindao Wu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1429812

Original Research

Accepted on 08 Jul 2024

HIGD1B, as a novel prognostic biomarker, is involved in regulating the tumor microenvironment and immune cell infiltration; its overexpression leads to poor prognosis in gastric cancer patients

in Cancer Immunity and Immunotherapy

Shibo Wang
Siyi Zhang
Xiaoxuan Li
Xiangxue Li
Shufen Zhao
Jing Guo
Shasha Wang
Rui Wang
Mengqi Zhang
Wensheng Qiu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1415148

Original Research

Accepted on 08 Jul 2024

Ceramide metabolism alterations contribute to Tumor Necrosis Factorinduced melanoma dedifferentiation and predict resistance to immune checkpoint inhibitors in advanced melanoma patients

in Cancer Immunity and Immunotherapy

Carine Dufau
Matthieu Genais
Elodie Mucher
Benjamin Jung
Virginie Garcia
Anne Montfort
Marie Tosolini
Christopher Clarke
Jeffrey A. Medin
Thierry Levade

Frontiers in Immunology

doi 10.3389/fimmu.2024.1421432

Original Research

Accepted on 08 Jul 2024

Comprehensive Investigation of Tumor Immune Microenvironment and Prognostic Biomarkers in Osteosarcoma Through Integrated Bulk and Single-Cell Transcriptomic Analysis

in Cancer Immunity and Immunotherapy

Shaoyan Shi
Li Zhang
Xiaohua Guo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1424950

Case Report

Accepted on 08 Jul 2024

Chronic hepatitis E virus-induced spinal cord atrophy in a patient with chronic lymphatic leukemia: a case report and interdisciplinary management proposal

in Cancer Immunity and Immunotherapy

Marvin Ritter
Olaposi Yomade
Ben-Ole Holtz
Stefanie Deinhardt-Emmer
Aaron Lawson McLean
Stefanie Hartinger
Julia Bechwar
Matthias Schwab
André Huss
Christian Marwin

Frontiers in Immunology

doi 10.3389/fimmu.2024.1445944

Systematic Review

Accepted on 08 Jul 2024

Efficacy and safety of PD-1/L1 inhibitors as first-line therapy for metastatic colorectal cancer: A meta-analysis

in Cancer Immunity and Immunotherapy

Zhilong Huang
Chunyan Li
Yanping Huang
Weiming Liang
Haiyun Tao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1425596

Original Research

Accepted on 08 Jul 2024

Dynamics of peripheral blood inflammatory index predict tumor pathological response and survival among patients with locally advanced non-small cell lung cancer underwent neoadjuvant immunochemotherapy: a multi-cohort retrospective study

in Cancer Immunity and Immunotherapy

Wenyu Zhai
Chao Zhang
Fangfang Duan
Jingdun Xie
Shuqin Dai
Yaobin Lin
Qihang Yan
Bingyu Rao
Liang Li
Yuheng Zhou

Frontiers in Immunology

doi 10.3389/fimmu.2024.1422717

Original Research

Accepted on 08 Jul 2024

Advancing Bladder Cancer Management: Development of a Prognostic Model and Personalized Therapy

in Cancer Immunity and Immunotherapy

Xiang Huang
Guotu Du
Ying Yang
Peng Su
Shicheng Chen
Chongjiong Cai
Tianyu Huang
Yu Zeng
Demei Tian
Yonggang Tao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1430792

Review

Accepted on 08 Jul 2024

LINC00518: A Key Player in Tumor Progression and Clinical Outcomes

in Cancer Immunity and Immunotherapy

Qiang Yi
Gangfeng Zhu
WeiJian Zhu
Jiaqi Wang
Xinting Ouyang
Kuan Yang
Jinghua Zhong

Frontiers in Immunology

doi 10.3389/fimmu.2024.1419576

Original Research

Accepted on 08 Jul 2024

CD47;Rag2;IL-2rγ triple knock-out mice pre-conditioning with busulfan could be a novel platform for generating hematopoietic stem cells engrafted humanized mice

in Cancer Immunity and Immunotherapy

Kang-Hyun Kim
Sang-Wook Lee
In-Jeoung Baek
Hye-Young Song
Seon-Ju Jo
Je-Won Ryu
Seung-Hee Ryu
Jin-Hee Seo
Jong-Choon Kim
Seung-Ho Heo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1365946

Editorial

Published on 08 Jul 2024

Editorial: Community series in tumor ablation and immunity, volume II

in Cancer Immunity and Immunotherapy

Yueyong Xiao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1457368

167 views

Perspective

Published on 08 Jul 2024

The therapeutic potential of exosomes in immunotherapy

in Cancer Immunity and Immunotherapy

Guangyao Li
Shuyi Zhang
Yitan Zou
Hongru Ai
Xinya Zheng
Kewen Qian
Changhai Lei
Wenyan Fu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1424081

352 views

Systematic Review

Published on 08 Jul 2024

Intratumoral high endothelial venules in solid tumors: a pooled study

in Cancer Immunity and Immunotherapy

Bin Wang
Yin Han
Jie Liu
Xinyao Zhang
Yaotiao Deng
Yu Jiang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1401118

209 views

Navigation group

Articles

Developing an advanced diagnostic model for hepatocellular carcinoma through multi-omics integration leveraging diverse cell-death patterns

Tumor associated macrophages in breast cancer progression: implications and clinical relevance

Targeting Mitochondrial Damage: Shining a New Light on Immunotherapy

Role of Tumor-Associated Macrophages in Hepatocellular Carcinoma: Impact, Mechanism and Therapy

HIGD1B, as a novel prognostic biomarker, is involved in regulating the tumor microenvironment and immune cell infiltration; its overexpression leads to poor prognosis in gastric cancer patients

Ceramide metabolism alterations contribute to Tumor Necrosis Factorinduced melanoma dedifferentiation and predict resistance to immune checkpoint inhibitors in advanced melanoma patients

Comprehensive Investigation of Tumor Immune Microenvironment and Prognostic Biomarkers in Osteosarcoma Through Integrated Bulk and Single-Cell Transcriptomic Analysis

Chronic hepatitis E virus-induced spinal cord atrophy in a patient with chronic lymphatic leukemia: a case report and interdisciplinary management proposal

Efficacy and safety of PD-1/L1 inhibitors as first-line therapy for metastatic colorectal cancer: A meta-analysis

Dynamics of peripheral blood inflammatory index predict tumor pathological response and survival among patients with locally advanced non-small cell lung cancer underwent neoadjuvant immunochemotherapy: a multi-cohort retrospective study

Advancing Bladder Cancer Management: Development of a Prognostic Model and Personalized Therapy

LINC00518: A Key Player in Tumor Progression and Clinical Outcomes

CD47;Rag2;IL-2rγ triple knock-out mice pre-conditioning with busulfan could be a novel platform for generating hematopoietic stem cells engrafted humanized mice

Editorial: Community series in tumor ablation and immunity, volume II

The therapeutic potential of exosomes in immunotherapy

Intratumoral high endothelial venules in solid tumors: a pooled study